Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › SARS-CoV Infection

SARS-CoV Infection

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for SARS-CoV Infection

12 trials tracked for SARS-CoV Infection: 5 in phase 3 or 4 and 5 with published results. The most-cited published study has 1406 citations.

12Trials tracked
5Phase 3 & 4
0Recruiting
5With published results
Phase distribution
Phase 4 1 Phase 3 4 Phase 2 6 Other / NA 1
  1. Phase 3 Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 Completed · 1,406 cited
  2. Phase 3 Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease Completed · 430 cited
  3. Phase 3 COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19) Completed · 245 cited
  4. Phase 3 VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study Completed · 42 cited
  5. Phase 4 Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection Completed · 30 cited
  6. Phase 2 Losartan for Patients With COVID-19 Requiring Hospitalization Completed
Show 6 more trials
  1. Phase 2 Sargramostim Use in COVID-19 to Recover Patient Health Completed
  2. Phase 2 COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations Completed
  3. Phase 2 Losartan for Patients With COVID-19 Not Requiring Hospitalization Completed
  4. Phase 2 Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine Completed
  5. Phase 2 GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19) Completed
  6. N/A SARS-CoV-2 Human Challenge Characterisation Study Completed

Showing the 12 most-cited and recently-updated of 12 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Metformin, fluvoxamine, or ivermectin for non-hospitalized COVID-19 adults in a Phase 3 trial
Infectious Disease Phase III
Metformin, fluvoxamine, or ivermectin for non-hospitalized COVID-19 adults in a Phase 3 trial Metformin Cuts Long Covid Risk by 40%
This randomized controlled trial in 1323 non-hospitalized adults with SARS-CoV-2 infection evaluated metformin, fluvoxamine, or ivermectin v…
A common diabetes pill taken early in Covid infection cuts the odds of developing long-term symptoms by 40%, offering new hope for millions.
CT.gov Apr 24, 2026